Navigation Links
Del Mar CEO Delivers Keynote Address at International Drug Discovery Science and Technology Conference
Date:11/8/2012

VANCOUVER, British Columbia, Nov. 8, 2012 /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. (DelMar) today announced that Mr. Jeffrey Bacha, the Company's President & CEO, delivered the keynote address entitled VAL-083 a Novel Chemotherapeutic Agent Developed in China for CML and Lung Cancer Shows Potential to Surpass Standard of Care in Glioblastoma Multiforme at the 2012 International Drug Discovery Science and Technology Conference in Nanjing, China.

In his address, Mr. Bacha highlighted DelMar's ongoing Phase I/II clinical trial with VAL-083 as a potential new therapy for patients suffering from glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

The trial, which is being conducted under an investigational new drug application (IND), in the United States is designed to evaluate the safety, tolerability and anti-tumor activity of VAL-083 in GBM patients who have failed front line therapy with Temodar™ and second-line therapy with Avastin™.  According to published data, approximately half of patients diagnosed with GBM will fail both front and second line therapy.  Currently, there are no approved treatments for these patients.

"DelMar has developed new data to re-position the dosing regimen for GBM in the context of modern care," stated Mr. Bacha in his address.  "We believe that this approach will provide benefit to patients who currently have very limited treatment options."

VAL-083, known as "DAG for Injection" in China, represents a first-in-class bi-functional alkylating agent.  The drug benefits from prior extensive clinical research sponsored by the United States National Cancer Institute (NCI), and is approved as a cancer chemotherapeutic in China for the treatment of chronic myelogenous leukemia (CML) and lung cancer.  Previous pre-clinical and clinical studies sponsored by the NCI suggest that VAL-083 may have activity against a range of tumor
'/>"/>

SOURCE Del Mar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
2. Direct Relief Delivers Hurricane Packs As FEMA Urges Preparedness
3. Bayer Partnership Delivers Industry-First Dose Management Offering
4. Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
5. MIOT Hospital Delivers First TrueBeam STx Radiotherapy Treatment in Chennai
6. New Fluke intrinsically safe digital multimeter delivers extreme ruggedness for use in potentially explosive environments
7. Dr. David Brailer and Stephen Dubner Keynotes for NYeC 2012 Digital Health Conference
8. Edwards Lifesciences Chief Medical Officer to Keynote the Inaugural MedTech Cardio 2012 Conference at the MD&M Minneapolis Exposition and Conference
9. Keynote Presentation at Upcoming International Microbiology & Genomics Meeting to Highlight Ability of Pressure BioSciences Patented PCT Platform to Improve Testing for Biological Threat Organisms, Human Infectious Diseases, and Contaminated Food P
10. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
11. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015  ResMed Inc. (NYSE: RMD ) today announced ... the quarter was $423.0 million, a 10 percent increase compared ... increase on a constant currency basis). Net income was $91.2 ... ended December 31, 2013. Diluted earnings per share for the ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015  Profil Institute for ... on diabetes and obesity, announced today a new textbook,  ... Development,  published by Springer, a leading global scientific publisher. ... analyze and illustrate techniques for use in early phase ...
(Date:1/22/2015)... Jan. 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/w25xpc/allergy ... Market by Allergen Source, Product & by End User - ... The global allergy diagnostics market is valued at ... a CAGR of 12.67%, to reach $2,230.72 million by 2019. ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the ... reducing the costs of an auto insurance policy . ... get lower prices for their vehicle insurance policies. The safety a ... policy costs. Because of this, drivers should always carry a ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... safest pain medication? Many people with osteoarthritis have ... painkillers called COX-2 inhibitors// to increased heart attack ... a COX-2 drug to other medications, including traditional ... naproxen. But although NSAIDs are effective at reducing ...
... the prestigious All India Institute of Medical Sciences (AIIMS) ... to its resident doctors association (RDA) that began early ... of AIIMS will elect eight representatives including president, vice ... Sixteen Candidates are contesting the elections that began at ...
... proof that limiting air travel can postpone the spread of flu. ... role// in the slow spread of flu across the globe every ... drop in air travel after the Sept. 11, 2001, attacks seemed ... ,“This is the first time that a study's been able ...
... watch kids comfortably settled in a beanbag, hastily nibbling from ... a television or computer screen. At a time when they ... opting for laidback activities. ,Parents, undoubtedly, have ... habit formation, as children emulate parents in their ways. In ...
... research conducted at the Hokkaido University, seaweed can be used ... of the body weight was observed in rats given fucoxanthin; ... the gut. The researchers are looking to a possibility of ... fat. Their study was presented to an American Chemical Society ...
... at the Uniformed Services University of the Health ... and the U.S. Department of Agriculture// (USDA) have ... intestinal roundworm infections, which affect more than 1.4 ... lead to more effective therapies against nematode parasites. ...
Cached Medicine News:Health News:AIIMS Goes to Polls Amid Reservation Issues 2Health News:Air travel restriction could hinder flu 2Health News:Seaweed to fight Obesity! 2Health News:Researchers Discover Breakthrough in Major Third World Scourge 2
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
Medicine Products: